PRAXIS PRECISION MEDICINES, INC. Cash and Cash Equivalents, Period Increase (Decrease)
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$165.46 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-11.
Discontinued › Cash Flow
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2021-05-11
- PRAXIS PRECISION MEDICINES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2021-03-31 was -$165.46M.
- PRAXIS PRECISION MEDICINES, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$38.57M.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month |
|---|---|---|
| 2021-03-31 | -$165.46M 10-Q · filed 2021-05-11 | |
| 2020-09-30 | $69.96M 10-Q · filed 2020-11-23 | |
| 2020-03-31 | -$38.57M 10-Q · filed 2021-05-11 | |
| 2019-09-30 | -$13.63M 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |